Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
M.D.C. Holdings sees Q3 home deliveries 2,200-2,500 » 06:14
07/28/22
07/28
06:14
07/28/22
06:14
MDC

M.D.C. Holdings

$36.34 /

+0.59 (+1.65%)

Sees Q3 average selling…

Sees Q3 average selling price $580,000-$590,000.

ShowHide Related Items >><<
MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

07/12/22 JPMorgan
M.D.C. Holdings price target lowered to $38 from $40.50 at JPMorgan
06/17/22 Wells Fargo
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo
04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

Earnings
M.D.C. Holdings reports Q2 EPS $2.59, consensus $2.50 » 06:13
07/28/22
07/28
06:13
07/28/22
06:13
MDC

M.D.C. Holdings

$36.34 /

+0.59 (+1.65%)

Reports Q2 revenue…

Reports Q2 revenue $1.45B, consensus $1.43B. Home sale revenues increased 6% to $1.45B from $1.37B. Average selling price of deliveries were up 14% to $572,000. Unit deliveries were down 7% to 2,536. "MDC delivered another quarter of strong profitability in the second quarter of 2022, generating earnings of $2.59 per diluted share, which represented a 23% increase over the second quarter of 2021," said MDC's executive chairman, Larry Mizel. "Our teams did an excellent job of executing during the quarter as we met or exceeded our stated guidance for deliveries, average sales price and home sales gross margin during what has become a more challenging operating environment. We also ended the quarter with a sold backlog value of over $4.44 billion, which was 8% higher on a year-over-year basis."

ShowHide Related Items >><<
MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

07/12/22 JPMorgan
M.D.C. Holdings price target lowered to $38 from $40.50 at JPMorgan
06/17/22 Wells Fargo
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo
04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

MDC M.D.C. Holdings
$36.34 /

+0.59 (+1.65%)

Recommendations
M.D.C. Holdings price target lowered to $38 from $40.50 at JPMorgan » 07:58
07/12/22
07/12
07:58
07/12/22
07:58
MDC

M.D.C. Holdings

$35.19 /

+0.235 (+0.67%)

JPMorgan analyst Michael…

JPMorgan analyst Michael Rehaut lowered the firm's price target on M.D.C. Holdings to $38 from $40.50 and keeps a Neutral rating on the shares. The analyst remains "cautious and less constructive" on the homebuilding group into the Q2 earnings season, as he expects sector headwinds to persist and says fundamentals "have only just begun to soften." This should result in "bad news" continuing to be "bad news" for the stocks this earnings season, or at minimum should not represent a positive catalyst, Rehaut tells investors in a research note. To reflect softening sales pace trends and increased incentives, the analyst lowered our second half of 2022 estimates for spec builders as well as 2023 estimates across the board.

ShowHide Related Items >><<
MDC M.D.C. Holdings
$35.19 /

+0.235 (+0.67%)

MDC M.D.C. Holdings
$35.19 /

+0.235 (+0.67%)

06/17/22 Wells Fargo
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo
04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
MDC M.D.C. Holdings
$35.19 /

+0.235 (+0.67%)

MDC M.D.C. Holdings
$35.19 /

+0.235 (+0.67%)

Syndicate
M.D.C. Holdings files $5.0B mixed securities shelf » 16:28
07/06/22
07/06
16:28
07/06/22
16:28
MDC

M.D.C. Holdings

$34.52 /

-0.325 (-0.93%)

As announced earlier…

As announced earlier today, the company announced a $5B mixed shelf. M.D.C. intends to "use the net proceeds from the sale of the securities offered under this prospectus and the prospectus supplement for general corporate purposes."

ShowHide Related Items >><<
MDC M.D.C. Holdings
$34.52 /

-0.325 (-0.93%)

MDC M.D.C. Holdings
$34.52 /

-0.325 (-0.93%)

06/17/22 Wells Fargo
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo
04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
MDC M.D.C. Holdings
$34.52 /

-0.325 (-0.93%)

MDC M.D.C. Holdings
$34.52 /

-0.325 (-0.93%)

Over a quarter ago
Downgrade
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo » 05:29
06/17/22
06/17
05:29
06/17/22
05:29
MDC

M.D.C. Holdings

$29.64 /

-2.47 (-7.69%)

Wells Fargo analyst Deepa…

Wells Fargo analyst Deepa Raghavan downgraded M.D.C. Holdings to Underweight from Equal Weight with a $27 price target. The analyst says fundamental U.S. housing data is set to get worse and feed into negative investor sentiment. The housing market slowdown was more evident at the value end of the chain and is slowly broadening, with the softness hitting quicker than many anticipated due to the unprecedented rise in interest rates, Raghavan tells investors in a research note.

ShowHide Related Items >><<
MDC M.D.C. Holdings
$29.64 /

-2.47 (-7.69%)

MDC M.D.C. Holdings
$29.64 /

-2.47 (-7.69%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
MDC M.D.C. Holdings
$29.64 /

-2.47 (-7.69%)

MDC M.D.C. Holdings
$29.64 /

-2.47 (-7.69%)

Hot Stocks
M.D.C. Holdings sees FY22 home deliveries 10,500-11,000  06:05
04/28/22
04/28
06:05
04/28/22
06:05
MDC

M.D.C. Holdings

$36.06 /

-0.92 (-2.49%)

 
ShowHide Related Items >><<
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

Hot Stocks
M.D.C. Holdings sees Q2 home deliveries 2,400-2,600 » 06:05
04/28/22
04/28
06:05
04/28/22
06:05
MDC

M.D.C. Holdings

$36.06 /

-0.92 (-2.49%)

Sees Q2 average selling…

Sees Q2 average selling price for Q2 unit deliveries $560,000-$570,000.

ShowHide Related Items >><<
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

Earnings
M.D.C. Holdings reports Q1 EPS $2.02, consensus $1.91 » 06:03
04/28/22
04/28
06:03
04/28/22
06:03
MDC

M.D.C. Holdings

$36.06 /

-0.92 (-2.49%)

Reports Q1 revenue…

Reports Q1 revenue $1.24B, consensus $1.21B. Reports average selling price of deliveries up 16% to $556,000. "MDC delivered strong results in the first quarter of 2022 both in terms of profitability and order activity," said MDC's' executive chairman, Larry Mizel. "We generated earnings of $2.02 per diluted share for the quarter, representing a 34% improvement over the first quarter of 2021. This significant increase to our bottom-line results was largely driven by a 19% year-over-year rise in home sale revenues and a 380-basis point improvement in our home sale gross margin to 25.7%. Our teams did an excellent job delivering homes in a timely manner this quarter in what continues to be a challenging supply chain environment, as we came in near the high-end of our stated guidance with total new home deliveries of 2,233 units."

ShowHide Related Items >><<
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

MDC M.D.C. Holdings
$36.06 /

-0.92 (-2.49%)

Hot Stocks
M.D.C. Holdings subsidiary to acquire homebuilding assets of The Jones Company » 06:02
04/22/22
04/22
06:02
04/22/22
06:02
MDC

M.D.C. Holdings

$37.33 /

-0.62 (-1.63%)

M.D.C. Holdings announced…

M.D.C. Holdings announced that its subsidiary, Richmond American Homes of Tennessee, has entered into an asset purchase agreement to acquire substantially all of the homebuilding assets of The Jones Company of Tennessee. Jones closed over 370 homes in fiscal year 2021 in the Nashville area with an average sales price of $564,000, generating revenues of $209M. MDC expects the transaction to close near the end of the second quarter of 2022, and it is expected to add approximately 10 selling communities, 1,700 controlled lots and 150 units in backlog to the operations of Richmond American. Consummation of the transaction is subject to the approval of the MDC board of directors and customary conditions.

ShowHide Related Items >><<
MDC M.D.C. Holdings
$37.33 /

-0.62 (-1.63%)

MDC M.D.C. Holdings
$37.33 /

-0.62 (-1.63%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
MDC M.D.C. Holdings
$37.33 /

-0.62 (-1.63%)

MDC M.D.C. Holdings
$37.33 /

-0.62 (-1.63%)

Periodicals
Mortgage rates spike to 5% amid post-pandemic price pressures, NY Times says » 16:56
04/14/22
04/14
16:56
04/14/22
16:56
DHI

D.R. Horton

$72.54 /

-1.505 (-2.03%)

, HOV

Hovnanian

$50.41 /

-2.23 (-4.24%)

, KBH

KB Home

$33.21 /

+0.04 (+0.12%)

, LEN

Lennar

$76.74 /

-1.21 (-1.55%)

, MDC

M.D.C. Holdings

$36.44 /

-0.57 (-1.54%)

, PHM

PulteGroup

$42.22 /

-0.415 (-0.97%)

, TOL

Toll Brothers

$46.18 /

-0.92 (-1.95%)

, BZH

Beazer Homes

$14.91 /

-0.33 (-2.17%)

, CAA

CalAtlantic

$53.37 /

+ (+0.00%)

, RLGY

Changed to HOUS

$13.33 /

-0.26 (-1.91%)

, Z

Zillow

$48.43 /

-0.36 (-0.74%)

, RMAX

RE/MAX Holdings

$26.39 /

+0.16 (+0.61%)

, RDFN

Redfin

$14.57 /

-0.65 (-4.27%)

Home buyers in this post…

Home buyers in this post pandemic world of inflated prices and supply chain disruptions are now facing the specter of mortgage rates at 5%, "for the first time in over a decade," wrote Conor Dougherty for the NY Times. U.S sponsored mortgage company, Freddie Mac, reported that rates on a 30-year fixed-rate mortgage "climbed from about 3 percent to 5 percent, the fastest jump since the 1980s," noted the NYT story. "On Thursday, Redfin said its index of home buyer demand had declined 3% over the past month," said the NYT. Publicly traded companies that may be impacted include: include Beazer Homes (BZH), CalAtlantic (CAA), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC), PulteGroup (PHM) , Toll Brothers (TOL), Realogy (RLGY), Zillow (Z), RE/MAX Holdings (RMAX) and Redfin (RDFN). Reference Link

ShowHide Related Items >><<
Z Zillow
$48.43 /

-0.36 (-0.74%)

TOL Toll Brothers
$46.18 /

-0.92 (-1.95%)

RMAX RE/MAX Holdings
$26.39 /

+0.16 (+0.61%)

RLGY Changed to HOUS
$13.33 /

-0.26 (-1.91%)

RDFN Redfin
$14.57 /

-0.65 (-4.27%)

PHM PulteGroup
$42.22 /

-0.415 (-0.97%)

MDC M.D.C. Holdings
$36.44 /

-0.57 (-1.54%)

LEN Lennar
$76.74 /

-1.21 (-1.55%)

KBH KB Home
$33.21 /

+0.04 (+0.12%)

HOV Hovnanian
$50.41 /

-2.23 (-4.24%)

DHI D.R. Horton
$72.54 /

-1.505 (-2.03%)

BZH Beazer Homes
$14.91 /

-0.33 (-2.17%)

DHI D.R. Horton
$72.54 /

-1.505 (-2.03%)

04/13/22 JPMorgan
D.R. Horton price target lowered to $82.50 from $100 at JPMorgan
04/05/22 Credit Suisse
D.R. Horton initiated with a Neutral at Credit Suisse
03/31/22 Barclays
D.R. Horton price target lowered to $104 from $125 at Barclays
03/25/22 Citi
D.R. Horton price target lowered to $97 from $108 at Citi
HOV Hovnanian
$50.41 /

-2.23 (-4.24%)

KBH KB Home
$33.21 /

+0.04 (+0.12%)

04/13/22 JPMorgan
KB Home price target lowered to $39 from $49 at JPMorgan
04/05/22 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
03/31/22 Barclays
KB Home price target lowered to $47 from $50 at Barclays
03/28/22 Wolfe Research
KB Home downgraded to Peer Perform at Wolfe Research after confidence 'wavered'
LEN Lennar
$76.74 /

-1.21 (-1.55%)

04/13/22 JPMorgan
Lennar price target lowered to $89 from $108 at JPMorgan
04/05/22 Credit Suisse
Lennar initiated with a Neutral at Credit Suisse
03/31/22 Barclays
Lennar price target lowered to $93 from $110 at Barclays
03/18/22 UBS
Lennar price target raised to $154 from $145 at UBS
MDC M.D.C. Holdings
$36.44 /

-0.57 (-1.54%)

04/13/22 JPMorgan
M.D.C. Holdings price target lowered to $39 from $49 at JPMorgan
03/10/22 JPMorgan
M.D.C. Holdings price target lowered to $49 from $66 at JPMorgan
02/02/22 Wedbush
M.D.C. Holdings price target lowered to $56 from $63 at Wedbush
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
PHM PulteGroup
$42.22 /

-0.415 (-0.97%)

04/13/22 JPMorgan
PulteGroup price target lowered to $48 from $57 at JPMorgan
04/05/22 Credit Suisse
PulteGroup initiated with an Outperform at Credit Suisse
03/31/22 Barclays
PulteGroup downgraded to Equal Weight from Overweight at Barclays
03/25/22 Citi
PulteGroup price target lowered to $55 from $62 at Citi
TOL Toll Brothers
$46.18 /

-0.92 (-1.95%)

04/13/22 JPMorgan
Toll Brothers price target lowered to $51 from $58 at JPMorgan
04/05/22 Credit Suisse
Toll Brothers initiated with an Outperform at Credit Suisse
03/31/22 Barclays
Toll Brothers price target lowered to $47 from $61 at Barclays
03/25/22 Citi
Toll Brothers price target lowered to $52 from $62 at Citi
BZH Beazer Homes
$14.91 /

-0.33 (-2.17%)

11/11/21 Zelman
Beazer Homes upgraded to Hold from Sell at Zelman
08/19/21 Janney Montgomery Scott
Beazer Homes initiated with a Buy at Janney Montgomery Scott
CAA CalAtlantic
$53.37 /

+ (+0.00%)

RLGY Changed to HOUS
$13.33 /

-0.26 (-1.91%)

02/22/22 Barclays
Realogy price target raised to $19 from $17 at Barclays
12/20/21 JPMorgan
Realogy upgraded ton positive housing backdrop at JPMorgan
12/20/21 JPMorgan
Realogy upgraded to Overweight from Neutral at JPMorgan
08/31/21 Keefe Bruyette
Realogy upgraded to Outperform from Market Perform at Keefe Bruyette
Z Zillow
$48.43 /

-0.36 (-0.74%)

03/30/22 Goldman Sachs
Zillow Group initiated with a Neutral at Goldman Sachs
03/17/22 Piper Sandler
Zillow Group price target lowered to $57 from $64 at Piper Sandler
03/04/22 Barclays
Zillow Group price target lowered to $50 from $72 at Barclays
02/18/22 Piper Sandler
Low inventory may be issue for Redin, Zillow, says Piper Sandler
RMAX RE/MAX Holdings
$26.39 /

+0.16 (+0.61%)

03/02/22 JonesTrading
RE/MAX Holdings initiated with a Buy at JonesTrading
02/28/22 Keefe Bruyette
RE/MAX Holdings price target lowered to $35 from $37 at Keefe Bruyette
09/22/21 Morgan Stanley
RE/MAX Holdings downgraded to Equal Weight from Overweight at Morgan Stanley
07/21/21 Berenberg
RE/MAX Holdings initiated with a Buy at Berenberg
RDFN Redfin
$14.57 /

-0.65 (-4.27%)

03/30/22 Goldman Sachs
Redfin initiated with a Neutral at Goldman Sachs
02/18/22 Stephens
Stephens downgrades Redfin to Equal Weight, awaits better re-entry point
02/18/22 Stephens
Redfin downgraded to Equal Weight from Overweight at Stephens
Z Zillow
$48.43 /

-0.36 (-0.74%)

TOL Toll Brothers
$46.18 /

-0.92 (-1.95%)

RMAX RE/MAX Holdings
$26.39 /

+0.16 (+0.61%)

RLGY Changed to HOUS
$13.33 /

-0.26 (-1.91%)

RDFN Redfin
$14.57 /

-0.65 (-4.27%)

PHM PulteGroup
$42.22 /

-0.415 (-0.97%)

MDC M.D.C. Holdings
$36.44 /

-0.57 (-1.54%)

LEN Lennar
$76.74 /

-1.21 (-1.55%)

KBH KB Home
$33.21 /

+0.04 (+0.12%)

HOV Hovnanian
$50.41 /

-2.23 (-4.24%)

DHI D.R. Horton
$72.54 /

-1.505 (-2.03%)

BZH Beazer Homes
$14.91 /

-0.33 (-2.17%)

Z Zillow
$48.43 /

-0.36 (-0.74%)

LEN Lennar
$76.74 /

-1.21 (-1.55%)

Z Zillow
$48.43 /

-0.36 (-0.74%)

TOL Toll Brothers
$46.18 /

-0.92 (-1.95%)

RMAX RE/MAX Holdings
$26.39 /

+0.16 (+0.61%)

RLGY Changed to HOUS
$13.33 /

-0.26 (-1.91%)

RDFN Redfin
$14.57 /

-0.65 (-4.27%)

PHM PulteGroup
$42.22 /

-0.415 (-0.97%)

LEN Lennar
$76.74 /

-1.21 (-1.55%)

KBH KB Home
$33.21 /

+0.04 (+0.12%)

HOV Hovnanian
$50.41 /

-2.23 (-4.24%)

DHI D.R. Horton
$72.54 /

-1.505 (-2.03%)

BZH Beazer Homes
$14.91 /

-0.33 (-2.17%)

Z Zillow
$48.43 /

-0.36 (-0.74%)

TOL Toll Brothers
$46.18 /

-0.92 (-1.95%)

RMAX RE/MAX Holdings
$26.39 /

+0.16 (+0.61%)

RDFN Redfin
$14.57 /

-0.65 (-4.27%)

PHM PulteGroup
$42.22 /

-0.415 (-0.97%)

LEN Lennar
$76.74 /

-1.21 (-1.55%)

KBH KB Home
$33.21 /

+0.04 (+0.12%)

DHI D.R. Horton
$72.54 /

-1.505 (-2.03%)

BZH Beazer Homes
$14.91 /

-0.33 (-2.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.